Inogen (INGN) announced it has entered into a strategic collaboration with Jiangsu Yuyue Medical Equipment & Supply. The strategic collaboration is expected to broaden Inogen’s product portfolio through distribution of certain respiratory products in the United States and select other territories, expand and enhance Inogen’s innovation pipeline through R&D collaboration, and accelerate the entry of Inogen’s brand into the Chinese market. In addition, Yuwell, through its affiliate, has agreed to invest approximately $27.2 million in Inogen, representing a 9.9% common equity interest, further cementing the collaboration and bolstering Inogen’s balance sheet.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INGN:
- Closing Bell Movers: KB Home jumps 7% after Q4 earnings beat
- Inogen reports preliminary Q4 revenue $79M, consensus $73.9M
- Inogen raises FY24 revenue view to $334.5M-$335.5M from $329M-$331M
- Inogen Expands U.S. Market with FDA Clearance
- Inogen gets FDA 510(k) clearance for the SIMEOX 200 Airway Clearance Device